Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Marimed (MRMD) Free Cash Flow (2016 - 2025)

Marimed (MRMD) has disclosed Free Cash Flow for 13 consecutive years, with $3.4 million as the latest value for Q4 2025.

  • Quarterly Free Cash Flow rose 330.86% to $3.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.5 million through Dec 2025, up 3288.65% year-over-year, with the annual reading at $6.5 million for FY2025, 226.14% up from the prior year.
  • Free Cash Flow for Q4 2025 was $3.4 million at Marimed, up from $1.4 million in the prior quarter.
  • The five-year high for Free Cash Flow was $10.6 million in Q3 2021, with the low at -$10.4 million in Q4 2022.
  • Average Free Cash Flow over 5 years is $1.4 million, with a median of $1.7 million recorded in 2024.
  • The sharpest move saw Free Cash Flow skyrocketed 1788.33% in 2021, then plummeted 337.4% in 2022.
  • Over 5 years, Free Cash Flow stood at $4.4 million in 2021, then tumbled by 337.4% to -$10.4 million in 2022, then soared by 173.91% to $7.7 million in 2023, then tumbled by 119.13% to -$1.5 million in 2024, then soared by 330.86% to $3.4 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at $3.4 million, $1.4 million, and -$1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.